AMELIORATION OF ARSENIC-INDUCED TOXICITY BY ETHANOL LEAF EXTRACT OF PHYLLANTUS AMARUS LINN AND VITAMIN C IN MALE ALBINO RATS

The ameliorative effect of ethanol leaf extract of Phyllantus amarus (EEPA) and vitamin C in arsenic-induced toxicity was studied. Thirty-six (36) male albino rats divided into six groups of six (6) rats each were used for the study. Arsenic toxicity was induced in three of the groups by daily intake of 100 ppm of arsenic as Dimethylarsenate (DMA) in their drinking water.  Two of the arsenic-exposed groups were treated with 200 and 500 mg/kg bwt of EEPA and vitamin C respectively. The third group was not treated during arsenic exposure. The fourth and fifth groups were positive control for P. amarus and Vitamin C respectively, while another group served as the normal control. All treatments were done orally for six weeks. The effects of treatments on lipid profile, lipid peroxidation and liver function were thereafter studied. Increased levels of total cholesterol, LDL-cholesterol and malondialdehyde (MDA) were observed in plasma and lymphocytes of untreated arsenic-exposed rats compared to the control group. Arsenic increased total cholesterol and LDL-cholesterol concentrations, while triacylglycerol concentration was reduced significantly. Treatments with EEPA and Vitamin C however ameliorated the dyslipidemia observed in arsenic-exposed groups. Exposure to DMA increased plasma activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) of the animals, while plasma activity of ALT in rats treated with Vitamin C was not different compared to the control. Both treatments however, had no significant effect (p > 0.05) on the activity of plasma AST. P. amarus may therefore play a role in ameliorating arsenic-induced dyslipidemia in male albino rats.     &nbsp

Impact of mothers’ socio-demographic factors and antenatal clinic attendance on neonatal mortality in Nigeria

Neonatal death is often referred to maternal complications during pregnancy, and other exogenous factors that exist around the time of birth or shortly after birth. The United Nations Sustainable Development Goals (UNSDG)-Goal 3, Targets 3.2 aimed at ending preventable deaths of newborns by demanding that all countries should reduce neonatal mortality to 12 per 1000 live births by 2030. The objective of the study was to examine the relationship between mothers’ socioeconomic and demographic factors on neonatal deaths in Nigeria. The study used quantitative data from the 2013 Nigeria Demographic and Health Surveys (NDHS). The data analyzed consisted of 26,826 women aged 15–49 years who had a live or dead birth within the 5 years preceding the survey. STATA 12 computer software was used to carry out data analyses. Data analyses were at univariate (frequency distribution), bivariate (chi-square) and due to the dichotomous nature of the outcome variable (i.e., whether a child was born alive or dead during the delivery; coded as (1, 0), a binary logistic regression was carried out to examine the relationships between various socio-demographic factors, antenatal clinic attendance and neonatal mortality in Nigeria. The results, among others, revealed that background factors of the women such as age, region, residence, education, and wealth status have a significant association with neonatal mortality (P < 0.05). The study also found that adequate antenatal clinic attendance helps to reduce neonatal deaths. The study recommended that women should be encouraged to observe regular antenatal clinic visits during pregnancy and also go for institutional delivery for possible reduction of neonates and infant deaths in Nigeria

Adverse reactions from community directed treatment with ivermectin (CDTI ) for onchocerciasis and loiasis in Ondo State, Nigeria

Onchocerciasis is an endemic disease in Ondo state, Nigeria. Community directed distribution of ivermectin is currently on-going in some local government areas of the state. Randomly selected persons (2,331 males and 2,469 females) were interviewed using a modified rapid assessment procedure for Loa loa (RAPLOA) to assess community directed treatment with ivermectin. The retrospective study evaluated the coverage, impacts and adverse reactions to the drug treatment. A questionnaire was administered by house-to-house visit in six local government areas, implementing community directed treatment with ivermectin (CDTI) in this bioclimatic zone. A total of 2,398 respondents were reported to have participated in the treatment. The overall ivermectin coverage of 49.96% was recorded (range 0 - 52% in different communities). Adverse reactions from ivermectin administration were experienced in 38% of individuals. Diverse adverse reactions experienced included predominantly itching (18.50%); oedema, especially of the face and the limbs (8.2%); rashes (3.4%) and body weakness (2.4%). Expulsion of intestinal worms occurred in 0.96% of the respondents. The occurrence of adverse reactions in relation to age categories was statistically significant. Neither fatal nor severe adverse reactions were reported by respondents. Significantly, despite experienced adverse reactions, continued participation, acceptability and compliance to ivermectin treatment was expressed by the various communities. This attitude is in consonance with the African Programme for Onchocerciasis Control (APOC) objectives